For East Europeans, Open Door To West Is A Revolving One

Researchers find visits increasingly necessary for career advancement, high-tech lab work, and hard currency earnings. As pluralism and democracy move to replace communist rule in Eastern Europe, researchers in the West can expect to see a steady increase in the number of scientists traveling to Western Europe, the United Kingdom, and the United States. "It seems to me that there are three key issues: one is freedom of travel, and in all of those [Eastern Europe] countries the travel barriers

Written byCarole Gan
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Researchers find visits increasingly necessary for career advancement, high-tech lab work, and hard currency earnings.
As pluralism and democracy move to replace communist rule in Eastern Europe, researchers in the West can expect to see a steady increase in the number of scientists traveling to Western Europe, the United Kingdom, and the United States.

"It seems to me that there are three key issues: one is freedom of travel, and in all of those [Eastern Europe] countries the travel barriers will be relaxed," says one official at the National Academy of Sciences (NAS) who is involved in foreign exchanges. "We've already seen it in Poland and Hungary. But that has to be balanced with the lack of access to hard currency, which will be a constraint, both for international cooperation and for upgrading the laboratories. Coupled with those two are the worries about the brain drain."

While some researchers have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies